However, our recent in vitro study showed that GGCX mutations, reported in VKCFD1 patients diagnosed with a PXE-like phenotype, do not respond with increasing levels of γ-carboxylated GRP after treatment with increasing vitamin K concentrations. The gene discussed is GGCX; the disease is pseudoxanthoma elasticum (inherited or acquired).